Serum guanidino compound levels in uremic pediatric patients treated with hemodialysis or continuous cycle peritoneal dialysis. Correlations between nerve conduction velocities and altered guanidino compound concentrations
- PMID: 7777105
- DOI: 10.1159/000188511
Serum guanidino compound levels in uremic pediatric patients treated with hemodialysis or continuous cycle peritoneal dialysis. Correlations between nerve conduction velocities and altered guanidino compound concentrations
Abstract
Serum levels of twelve guanidino compounds (GCs) and nerve conduction velocities were determined in a dialyzed renal insufficient pediatric population. Two dialytic groups were considered: one subjected to hemodialysis (HD, 11 patients) and one subjected to continuous cycle peritoneal dialysis (CCPD, 13 patients). Before HD, marked increases were found for guanidino-succinic acid (207 times), methylguanidine (> or = 67 times), argininic acid (24 times), creatinine and alpha-N-acetylarginine (18 times) and guanidine (> or = 14 times) when compared to controls. Important significant increases were still present after an HD session for guanidinosuccinic acid (49 times), methylguanidine (34 times), creatinine (7 times) and alpha-N-acetylarginine and guanidine (6 times). After HD, creatine, arginine and homoarginine were lower than in controls. All GCs, with the exception of creatine, decreased significantly after a single HD session with percentage decrease ranging between 40% (for arginine) and 77% (for guanidinosuccinic acid). Creatine decreased in a statistically nonsignificant manner by 48%. Marked increases were found in the CCPD group for guanidinosuccinic acid (114 times), alpha-N-acetylarginine (12 times), argininic acid (15 times), creatinine (22 times), guanidine (> or = 11 times) and methylguanidine (> or = 48 times). Concentrations of guanidinosuccinic acid before and after HD and in CCPD were comparable to those reported to be toxic in vitro and in vivo. No clinical or electrophysiological indications of polyneuropathy were observed in our population. Sensory and motor nerve conduction studies showed few abnormalities apart from a significant correlation between argininic acid concentration or guanidine levels and the peroneal nerve conduction velocity in the CCPD-treated group.
Similar articles
-
Guanidino compounds in uraemic dialysed patients.Clin Chim Acta. 1986 Jun 15;157(2):143-50. doi: 10.1016/0009-8981(86)90220-2. Clin Chim Acta. 1986. PMID: 3719996
-
Serum guanidino compound levels and the influence of a single hemodialysis in uremic patients undergoing maintenance hemodialysis.Nephron. 1987;45(4):291-5. doi: 10.1159/000184166. Nephron. 1987. PMID: 3587469
-
Serum guanidino compound levels and clearances in uremic patients treated with continuous ambulatory peritoneal dialysis.Nephron. 1990;54(4):307-12. doi: 10.1159/000185885. Nephron. 1990. PMID: 2325795
-
[Chronic renal failure and guanidino compounds].Yakugaku Zasshi. 1997 Nov;117(10-11):673-80. doi: 10.1248/yakushi1947.117.10-11_673. Yakugaku Zasshi. 1997. PMID: 9414581 Review. Japanese.
-
Guanidino compounds as uremic (neuro)toxins.Semin Dial. 2009 Jul-Aug;22(4):340-5. doi: 10.1111/j.1525-139X.2009.00577.x. Semin Dial. 2009. PMID: 19708978 Review.
Cited by
-
Cationic uremic toxins affect human renal proximal tubule cell functioning through interaction with the organic cation transporter.Pflugers Arch. 2013 Dec;465(12):1701-14. doi: 10.1007/s00424-013-1307-z. Epub 2013 Jun 29. Pflugers Arch. 2013. PMID: 23812163
-
Cerebrocellular swelling in the presence of uraemic guanidino compounds: ameliorative effects of taurine.Neurochem Res. 2005 Dec;30(12):1465-70. doi: 10.1007/s11064-005-8823-y. Neurochem Res. 2005. PMID: 16362765
-
Human age-declined saliva metabolic markers determined by LC-MS.Sci Rep. 2021 Sep 13;11(1):18135. doi: 10.1038/s41598-021-97623-7. Sci Rep. 2021. PMID: 34518599 Free PMC article.
-
Combining hemodialysis with peritoneal dialysis improves cognitive function: a three-case report.CEN Case Rep. 2024 Dec;13(6):517-521. doi: 10.1007/s13730-024-00880-4. Epub 2024 Apr 26. CEN Case Rep. 2024. PMID: 38668925 Free PMC article.
-
Gut microbiota dysbiosis contributes to the development of hypertension.Microbiome. 2017 Feb 1;5(1):14. doi: 10.1186/s40168-016-0222-x. Microbiome. 2017. PMID: 28143587 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical